- Report
- July 2019
- 1172 Pages
United States
From €12014EUR$12,500USD£10,303GBP
- Report
- July 2019
- 500 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- May 2019
- 500 Pages
Global
From €8170EUR$8,500USD£7,006GBP
- Report
- March 2020
- 104 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- March 2023
- 256 Pages
Global
From €5507EUR$5,730USD£4,723GBP
- Report
- September 2019
Global
From €5161EUR$5,370USD£4,426GBP
- Report
- November 2023
- 145 Pages
Latin America
From €2882EUR$2,999USD£2,472GBP
- Report
- November 2023
- 150 Pages
Europe
From €2882EUR$2,999USD£2,472GBP
- Report
- November 2023
- 145 Pages
Middle East, Africa
From €2882EUR$2,999USD£2,472GBP
- Report
- November 2023
- 145 Pages
North America
From €2882EUR$2,999USD£2,472GBP
- Report
- November 2023
- 150 Pages
Asia Pacific
From €3363EUR$3,499USD£2,884GBP
The Urinalysis market within the In Vitro Diagnostics (IVD) industry is a segment of the larger IVD market that focuses on the analysis of urine samples. Urinalysis is used to detect and diagnose a variety of conditions, such as urinary tract infections, kidney diseases, and diabetes. It is also used to monitor the effectiveness of treatments. Urinalysis tests are typically performed in laboratories, hospitals, and clinics, and the results are used to guide patient care.
The Urinalysis market is highly competitive, with a variety of products and services available. Companies in the market offer a range of products, including automated analyzers, reagents, and consumables. These products are used to perform a variety of tests, such as urine chemistry, urine sediment, and urine culture.
Some companies in the Urinalysis market include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, and Beckman Coulter. Show Less Read more
